212 related articles for article (PubMed ID: 16586496)
1. International study on low-grade primary central nervous system lymphoma.
Jahnke K; Korfel A; O'Neill BP; Blay JY; Abrey LE; Martus P; Poortmans PM; Shenkier TN; Batchelor TT; Neuwelt EA; Raizer JJ; Schiff D; Pels H; Herrlinger U; Stein H; Thiel E
Ann Neurol; 2006 May; 59(5):755-62. PubMed ID: 16586496
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Hoang-Xuan K; Taillandier L; Chinot O; Soubeyran P; Bogdhan U; Hildebrand J; Frenay M; De Beule N; Delattre JY; Baron B;
J Clin Oncol; 2003 Jul; 21(14):2726-31. PubMed ID: 12860951
[TBL] [Abstract][Full Text] [Related]
3. Low-grade primary central nervous system lymphoma in immunocompetent patients.
Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
[TBL] [Abstract][Full Text] [Related]
4. Patterns of treatment in older adults with primary central nervous system lymphoma.
Panageas KS; Elkin EB; Ben-Porat L; Deangelis LM; Abrey LE
Cancer; 2007 Sep; 110(6):1338-44. PubMed ID: 17647247
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.
Gavrilovic IT; Hormigo A; Yahalom J; DeAngelis LM; Abrey LE
J Clin Oncol; 2006 Oct; 24(28):4570-4. PubMed ID: 17008697
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.
Juergens A; Pels H; Rogowski S; Fliessbach K; Glasmacher A; Engert A; Reiser M; Diehl V; Vogt-Schaden M; Egerer G; Schackert G; Reichmann H; Kroschinsky F; Bode U; Herrlinger U; Linnebank M; Deckert M; Fimmers R; Schmidt-Wolf IG; Schlegel U
Ann Neurol; 2010 Feb; 67(2):182-9. PubMed ID: 20225195
[TBL] [Abstract][Full Text] [Related]
7. Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group.
Shenkier TN; Blay JY; O'Neill BP; Poortmans P; Thiel E; Jahnke K; Abrey LE; Neuwelt E; Tsang R; Batchelor T; Harris N; Ferreri AJ; Ponzoni M; O'Brien P; Rubenstein J; Connors JM
J Clin Oncol; 2005 Apr; 23(10):2233-9. PubMed ID: 15800313
[TBL] [Abstract][Full Text] [Related]
8. [Treatment results and the prognosis in patients with localization of non-Hodgkins-lymphoma in the central nervous system].
Paulus JA; Bos GM; Löwenberg B; Van Den Bent MJ
Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2196-200. PubMed ID: 9864481
[TBL] [Abstract][Full Text] [Related]
9. Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s.
Shibamoto Y; Ogino H; Hasegawa M; Suzuki K; Nishio M; Fujii T; Kato E; Ishihara S; Sougawa M; Kenjo M; Kawamura T; Hayabuchi N
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):809-13. PubMed ID: 15936564
[TBL] [Abstract][Full Text] [Related]
10. Combined-modality therapy for primary central nervous system lymphoma: long-term data from a Phase II multicenter study (Trans-Tasman Radiation Oncology Group).
O'Brien PC; Roos DE; Pratt G; Liew KH; Barton MB; Poulsen MG; Olver IN; Trotter GE;
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):408-13. PubMed ID: 16198065
[TBL] [Abstract][Full Text] [Related]
11. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
Kiewe P; Fischer L; Martus P; Thiel E; Korfel A
Cancer; 2008 Apr; 112(8):1812-20. PubMed ID: 18318432
[TBL] [Abstract][Full Text] [Related]
12. Consideration of aggressive therapeutic strategies for primary testicular lymphoma.
Park BB; Kim JG; Sohn SK; Kang HJ; Lee SS; Eom HS; Kwon HC; Oh SY; Kang JH; Oh SJ; Shin HJ; Suh C; Kim JH; Kim HY; Kim K; Ryoo BY; Kim WS
Am J Hematol; 2007 Sep; 82(9):840-5. PubMed ID: 17563078
[TBL] [Abstract][Full Text] [Related]
13. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
Shah GD; Yahalom J; Correa DD; Lai RK; Raizer JJ; Schiff D; LaRocca R; Grant B; DeAngelis LM; Abrey LE
J Clin Oncol; 2007 Oct; 25(30):4730-5. PubMed ID: 17947720
[TBL] [Abstract][Full Text] [Related]
14. Primary bone lymphoma: treatment results and prognostic factors with long-term follow-up of 82 patients.
Beal K; Allen L; Yahalom J
Cancer; 2006 Jun; 106(12):2652-6. PubMed ID: 16700039
[TBL] [Abstract][Full Text] [Related]
15. Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51.
Laack NN; Ballman KV; Brown PB; O'Neill BP;
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1429-39. PubMed ID: 16863926
[TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
[TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
[TBL] [Abstract][Full Text] [Related]
18. Results of treatment of 112 cases of primary CNS lymphoma.
Yamanaka R; Morii K; Shinbo Y; Homma J; Sano M; Tsuchiya N; Yajima N; Tamura T; Hondoh H; Takahashi H; Kakuma T; Tanaka R
Jpn J Clin Oncol; 2008 May; 38(5):373-80. PubMed ID: 18413337
[TBL] [Abstract][Full Text] [Related]
19. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.
Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U
Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system.
Jahnke K; Thiel E; Martus P; Schwartz S; Korfel A
Ann Hematol; 2006 Jan; 85(1):45-50. PubMed ID: 16132909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
